Some of the qualifications that make someone an ideal candidate for this injection include: Having a body mass index (BMI) of 27 kg/m2 or greater and at least one weight-related condition like high blood pressure, Type 2 diabetes, or high cholesterol Having a BMI of 30 kg/m2 or greater People who are not good candidates for the ReStart Shot include those with the following: History of medullary thyroid cancer History of gallbladder disease History of pancreatitis Multiple endocrine neoplasia syndrome type 2 (MEN2) The ReStart Shot The ReStart Shot is a once-weekly injection that is administered into the tissue of the abdomen, back of the arm, or thigh

Those with pre-existing gastrointestinal conditions, such as irritable bowel syndrome or inflammatory bowel disease, should receive individualised guidance from a registered dietitian, as standard fibre recommendations may require modification (for example, emphasising soluble fibre or considering a dietitian-supervised low FODMAP approach)
The most common adverse events are gastrointestinal issues like nausea
This prevents reproduction
Conversion at 5mg/mL The 5mg/mL concentration is arguably the most versatile for retatrutide
Plan sponsors need to adopt formulary and benefit designs that account for this and make sure that GLP-1s are used for the indication prescribed